Company intelligence / Profile preview

Casimir

Plymouth, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Casimir is a rare-disease focused clinical research organization specializing in development and validation of patient-centered, often home-based and virtual outcome measures (e.g., Duchenne Video Assessment) to support decentralized and hybrid trials in more than 20 rare diseases; it does not develop its own drugs but supports sponsors’ clinical programs.[1][3][4][8][9]

Therapeutic areas: NeurologyRare Diseases
Industry: Contract Research Organization

Partnerships

Emmes (integration into Emmes’ Orphan Reach rare disease center of excellence after acquisition)[1][3][4][9]Jain Foundation (work on dysferlinopathy and related muscular dystrophies as a contract research organization partner)[8]

Beyond the preview

Go deeper on Casimir.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Casimir.

Explore the full profile